3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
10
Phase 3
5
Phase 2/3
2
Phase 1/2
2
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
42
Rectal Neoplasms
31
Colorectal Neoplasms
31
Pancreatic Neoplasms
30
Neoplasms
26
Stomach Neoplasms
20
Neoplasm Metastasis
17
Colonic Neoplasms
13
Unspecified Adult Solid Tumor, Protocol Specific
12
Esophageal Neoplasms
12
Carcinoma, Non-Small-Cell Lung
11
Solid Tumor
7
Biliary Tract Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
4
Ovarian Neoplasms
4
Liver Neoplasms
4
Carcinoma, Hepatocellular
4
Bile Duct Neoplasms
4
Triple Negative Breast Neoplasms
3
Prostatic Neoplasms
3
Melanoma
3
Head and Neck Neoplasms
3
Gallbladder Neoplasms
3
Carcinoma, Renal Cell
3
Carcinoma, Ovarian Epithelial
3
Appendiceal Neoplasms
3
Anus Neoplasms
3
Adenocarcinoma
3
Vaginal Neoplasms
2
Uterine Cervical Neoplasms
2
Interventions
Radiotherapy
7
Cisplatin
7
Irinotecan
5
Fluorouracil
5
pembrolizumab
4
Docetaxel
4
Paclitaxel
3
Oxaliplatin
3
durvalumab
2
Radiation
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Leucovorin
2
Drug Therapy
2
Carboplatin
2
vandetanib
1
toripalimab
1
tislelizumab
1
spartalizumab
1
ribociclib
1
obinutuzumab
1
naptumomab estafenatox
1
matuzumab
1
futibatinib
1
adavosertib
1
Vorinostat
1
Topotecan
1
Taxes
1
Surgical Procedures, Operative
1
Sunitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Adenocarcinoma Of Esophagus
×
Capecitabine
×
Clear all
NCT03641547
2024-07-18
CHARIOT
University of Oxford
Phase 1
Completed
36 enrolled
24 charts